B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity—A Meta-Analysis

Up to 15% of coronavirus disease 2019 (COVID-19) patients experience severe clinical presentation, resulting in acute respiratory distress (ARDS) and finally death. N-terminal natriuretic peptide (NT-proBNP) is associated with a worse prognosis in patients with ARDS. However, whether or not this pep...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorrentino, Sabato, Cacia, Michele, Leo, Isabella, Polimeni, Alberto, Sabatino, Jolanda, Spaccarotella, Carmen Anna Maria, Mongiardo, Annalisa, De Rosa, Salvatore, Indolfi, Ciro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564464/
https://www.ncbi.nlm.nih.gov/pubmed/32932743
http://dx.doi.org/10.3390/jcm9092957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564464/
https://www.ncbi.nlm.nih.gov/pubmed/32932743
http://dx.doi.org/10.3390/jcm9092957

Ejemplares similares